Get Your Free Report

Runaway Healthcare Tech Stock (up 4-Fold) about to Really Take off?

Sign up to get our daily tech investing e-letter, Profit Confidential, along with our special offers and to get our research report,

Runaway Healthcare Tech Stock (up 4-Fold) about to Really Take off?

They’re both FREE!

We respect your privacy! That's a promise! And you can opt out at any time.


The advancement in technology we have witnessed in the 21st century has made some investors filthy rich. Stocks of cutting-edge tech companies have been the leaders of the market rally we’ve enjoyed over the past 10 years. And when you apply cutting-edge technology to healthcare, the outcome could be explosive growth.

Case in point is this medical technology company we’ve discovered that designs and develops glucose monitoring systems to improve the lives of people with diabetes. They’ve designed an implantable glucose monitoring device that can measure sugar levels in people for up to 90 days compared to only five or seven days for most systems on the market right now.

According to the International Diabetes Federation, 371 million people around the world have diabetes and about half of them are undiagnosed! Imagine, no more pricking-the-finger to measure blood sugar levels for millions of people. No wonder this stock has already quadrupled!

Get the full story on this stock and why we believe it will be the next big tech winner in a special investor research report we've just released called, Runaway Healthcare Tech Stock (up 4-Fold) about to Really Take off? It’s yours with our compliments when you opt in for our FREE tech investing e-letter, Profit Confidential.

Get Your Free Report

Runaway Healthcare Tech Stock (up 4-Fold) about to Really Take off?

Sign up to get our daily tech investing e-letter, Profit Confidential, along with our special offers and to get our research report,

Runaway Healthcare Tech Stock (up 4-Fold) about to Really Take off?

They’re both FREE!

We respect your privacy! That's a promise! And you can opt out at any time.


Every investor has a story about the big one that got away. Consider Amazon.com. It was both a “top dog” and a first mover in e-commerce. If you had invested just $10,000 in the online retailer back in 1997, your stake would be worth more than $4 million today. Amazon is hardly an exception. The list of the stock market’s greatest all-time winners is filled with pioneering companies:

Amgen…eBay…Oracle…Google…Netflix…Apple…Qualcomm…Facebook…and more. These innovative firms all made fortunes for their early investors. Finding the next great tech company is our main goal at Profit Confidential. Since 1986, our firm has been dedicated to helping investors earn superior returns through unbiased financial research. We strive to deliver to our readers analyses of current tech trends, events, and investment opportunities in this daily bulletin. Combined, we have more than 100 years of experience in analyzing various investment markets. Our analysts include MBAs, BAs, B.Comms, P. Engs, MAs, and LLBs. Get our opinions and forecasts coming to you daily when you opt in for Profit Confidential now!


George Leong, B.Comm.

George Leong is a senior analyst at Lombardi Publishing Corporation. He has been involved in analyzing the stock market for three decades, employing both fundamental and technical analysis. His overall market timing and trading knowledge are extensive in the areas of small-cap research and options trading.

George is the editor of several of Lombardi’s popular financial newsletters, including Red-Hot Small-Caps, Lombardi’s Special Situations, Obscene Profits, Pennies to Millions, and 100% Letter.

In the past, George has written technical and fundamental columns for numerous stock market news web sites, and he is the author of two books, Quick Wealth Options Strategy and Mastering 7 Proven Options Strategies. Prior to starting with Lombardi, George was employed as a financial analyst with Globe Information Services.

Stephen Karmazyn, BA

Stephen Karmazyn is an analyst at Profit Confidential, where he focuses on reporting breaking news in the technology and emerging industries, with a spotlight on the new marijuana sector.

Stephen has written on tech for a variety of publications, including The Financial Post, The Globe and Mail, and The Ottawa Business Journal. He served as the web editor for Techopia, a tech-centered newsblog focused on emerging start-up companies.

John Whitefoot, BA

John Whitefoot is an analyst at Lombardi Publishing Corporation, specializing in low-priced investment opportunities.

John has been a financial writer since the late 1990s and has written on everything from penny stocks, to blue-chip stocks, to the broader issues that affect the stock market.

John has profiled more than 1,000 low-priced stocks, researching and covering numerous sectors including health care, media, manufacturing, IT, education, hospitality, natural resources, retail, and the new marijuana industry.

John is primarily a fundamental analyst. His focus is on “off-the-radar” situations with big upside potential for the individual investor.

Get Your Free Report

Runaway Healthcare Tech Stock (up 4-Fold) about to Really Take off?

Sign up to get our daily tech investing e-letter, Profit Confidential, along with our special offers and to get our research report,

Runaway Healthcare Tech Stock (up 4-Fold) about to Really Take off?

They’re both FREE!

We respect your privacy! That's a promise! And you can opt out at any time.